Collegium Pharmaceutical (COLL) Non-Current Deferred Tax Liability (2018 - 2026)

Collegium Pharmaceutical has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $41.0 million in Q2 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $41.0 million in Q2 2026; TTM through Jun 2026 was $41.0 million, a N/A change from a year earlier, with the FY2018 full-year figure at $11.5 million, changed N/A from the prior year.
• Non-Current Deferred Tax Liability was $41.0 million for Q2 2026 at Collegium Pharmaceutical, up from $11.5 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $41.0 million in Q2 2026, with the low at $41.0 million in Q2 2026.